AtriCure Q1 revenue $123.6M (+13.6% YoY); net loss improves to $6.7M from $13.2M

AtriCure, Inc.

2025-Q1 EPS reported -$0.14 revenue$123,620,000

Revenue $123.6M (+13.6% YoY; +14.1% constant currency); U.S. $101.1M (+12.1%), International $22.5M (+20.8%).
Net loss $6.7M ($0.14 per share) improved from $13.2M ($0.28 per share) a year ago.
Adjusted EBITDA $8.8M, up from $2.8M in Q1 2024; gross margin 74.9% (+27 bps).
Growth driven by EnCompass clamp, cryoSPHERE MAX probes, AtriClip Flex-Mini device launches.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.